Dementia diagnosis in the anti-amyloid era

被引：0
|
作者：
不详
机构：
来源：
LANCET NEUROLOGY | 2024年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [21] Anti-amyloid β Antibody Therapies for Alzheimer's Disease: Association between the Target of Amyloid β Aggregates and the Clinical Efficacy of Anti-amyloid β Antibody
    Noguchi-Shinohara, Moeko
    Ono, Kenjiro
    INTERNAL MEDICINE, 2024,
  • [22] Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti-amyloid therapy
    Fessel, Jeffrey
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
  • [23] Challenges of Implementing Anti-Amyloid Therapies in the Clinic
    Apostolova, Liana G.
    ANNALS OF NEUROLOGY, 2023, 94 : S282 - S282
  • [24] The Impact of Anti-Amyloid Immunotherapies on Stroke Care
    Bilodeau, Philippe A.
    Dickson, John R.
    Kozberg, Mariel G.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [25] Anti-amyloid immunotherapy in Alzheimer's Disease
    Orgogozo, J. -M.
    REVUE NEUROLOGIQUE, 2008, 164 : F95 - F97
  • [26] From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer's Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients
    Tsantzali, Ioanna
    Boufidou, Fotini
    Sideri, Eleni
    Mavromatos, Antonis
    Papaioannou, Myrto G.
    Foska, Aikaterini
    Tollos, Ioannis
    Paraskevas, Sotirios G.
    Bonakis, Anastasios
    Voumvourakis, Konstantinos I.
    Tsivgoulis, Georgios
    Kapaki, Elisabeth
    Paraskevas, George P.
    BIOMEDICINES, 2021, 9 (10)
  • [27] An Industry Perspective: Future of Anti-Amyloid Trials
    Kramer, Lynn D.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2020, 7 (03): : 142 - 143
  • [28] The molecular mechanisms of the anti-amyloid effects of phenols
    Shoval, Hila
    Lichtenberg, Dov
    Gazit, Ehud
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2007, 14 (01): : 73 - 87
  • [29] Following nature's anti-amyloid strategy
    Lansbury, PT
    NATURE BIOTECHNOLOGY, 2001, 19 (02) : 112 - 113
  • [30] An Industry Perspective: Future of Anti-Amyloid Trials
    Lynn D. Kramer
    The Journal of Prevention of Alzheimer's Disease, 2020, 7 : 142 - 143
12345